Medinotec Inc. (MDNC)

SEC fundamentals · as filed in 10-Q FY2026, period ended Aug 31, 2026 · updated Oct 10, 2026

Verified against EDGAR
Total Assets
$7.0M
Stockholders' Equity
$5.9M
Cash & Equivalents
$2.6M
Long-Term Debt
—

as filed in 10-Q FY2026, period ended Aug 31, 2026 · View filings on EDGAR ↗

In its 10-Q for the period ended Aug 31, 2026, Medinotec Inc. reported revenue of $3.2M, net income of $40,866, and total assets of $7.0M. Every figure below is taken directly from Medinotec Inc.'s SEC filings: each links to the source document on EDGAR.

Revenue trend

Revenue · FY2023–FY2026 · as reported

$9.7M$4.7M-$404,688
FY2023FY2024FY2025FY2026
Revenue$9.7MNet income$794,502
FY2023 revenue
$999,579
FY2026 revenue
$9.7M

Revenue and net income by fiscal year

As reported in each year’s annual filing · USD

Fiscal yearRevenueNet income
FY2026$9.7M$794,502
FY2025$9.1M$2.2M
FY2024$5.0M-$404,688
FY2023$999,579-$352,735

Recent SEC filings

Filed by the registrant · newest first · insider forms and holder schedules not included

FormFiledSource
10-QOct 8, 2026on EDGAR ↗
10-QJul 9, 2026on EDGAR ↗
10-KMay 28, 2026on EDGAR ↗
8-KJan 20, 2026on EDGAR ↗
10-QJan 9, 2026on EDGAR ↗
DEF 14AJan 2, 2026on EDGAR ↗
10-QOct 8, 2025on EDGAR ↗
10-QJul 16, 2025on EDGAR ↗
10-KMay 29, 2025on EDGAR ↗
8-KJan 27, 2025on EDGAR ↗

All filings on EDGAR ↗

Balance Sheet

as of Aug 31, 2026 · 10-Q

Total Assets$7.0Msource ↗
Stockholders’ Equity$5.9Msource ↗
Cash & Equivalents$2.6Msource ↗
Long-Term Debt—source ↗

Income Statement

10-Q (quarterly) · period ended Aug 31, 2026

Revenue$3.2Msource ↗
Net Income$40,866source ↗
Operating Income$202,723source ↗
Gross Profit$1.6Msource ↗
Cost of Revenue$1.6Msource ↗
R&D Expense$22,076source ↗

Per Share & Cash Flow

10-Q (quarterly) · period ended Aug 31, 2026

EPS (diluted)$0.00source ↗
EPS (basic)$0.00source ↗
Shares Outstanding11.8Msource ↗
Cash from Operations$107,526source ↗
Cash from Financing—source ↗
Cash from Investing-$46,635source ↗

Restatement history

Point-in-time

5 of 107 annual fact-keys were materially restated between filings: what Medinotec Inc. first reported differed from what it later filed. We keep every vintage of every annual figure, each keyed to its EDGAR accession.

See each original-vs-restated value, and query any company as of any past date, with the point-in-time API.

Deeper fundamentals

A free API key reaches MDNC’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.

Programmatic access

Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.

These fundamentals, as filed
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/MDNC

MCP tool: get_sec_fundamentals ticker=MDNC

The same figures as they were known on any past date
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/MDNC/as-of/YYYY-MM-DD

MCP tool: get_asof_fundamentals ticker=MDNC as_of=YYYY-MM-DD

Fiscal-year trajectory: revenue, margins, free cash flow
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/MDNC/history

MCP tool: get_fundamentals_history ticker=MDNC

Leverage, liquidity, margin and return ratios
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/financial-health/MDNC

MCP tool: get_financial_health ticker=MDNC

Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.